Merck KGaA (MKGAY) Receives $65.00 Consensus Price Target from Analysts

Shares of Merck KGaA (NASDAQ:MKGAY) have earned a consensus rating of “Hold” from the nine analysts that are presently covering the stock. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $65.00.

Separately, HSBC Holdings plc cut Merck KGaA from a “hold” rating to a “reduce” rating in a report on Friday, April 7th.

Shares of Merck KGaA (NASDAQ:MKGAY) opened at 37.05 on Friday. Merck KGaA has a 12-month low of $30.04 and a 12-month high of $38.11. The company has a market capitalization of $48.37 billion and a P/E ratio of 27.90. The company’s 50 day moving average is $37.10 and its 200 day moving average is $35.59.

TRADEMARK VIOLATION WARNING: “Merck KGaA (MKGAY) Receives $65.00 Consensus Price Target from Analysts” was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this piece of content can be viewed at

Merck KGaA Company Profile

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company operates through four business segments: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin.

5 Day Chart for NASDAQ:MKGAY

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply